Product Details for NDA 209311
JORNAY PM (METHYLPHENIDATE HYDROCHLORIDE)
20MG
Marketing Status: Prescription
40MG
Marketing Status: Prescription
60MG
Marketing Status: Prescription
80MG
Marketing Status: Prescription
100MG
Marketing Status: Prescription
20MG
Marketing Status: Prescription
Active Ingredient: METHYLPHENIDATE HYDROCHLORIDE
Proprietary Name: JORNAY PM
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 20MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N209311
Product Number: 001
Approval Date: Aug 8, 2018
Applicant Holder Full Name: IRONSHORE PHARMACEUTICALS AND DEVELOPMENT INC
Marketing Status: Prescription
Patent and Exclusivity Information
JORNAY PM (METHYLPHENIDATE HYDROCHLORIDE)
Proprietary Name: JORNAY PM
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 20MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N209311
Product Number: 001
Approval Date: Aug 8, 2018
Applicant Holder Full Name: IRONSHORE PHARMACEUTICALS AND DEVELOPMENT INC
Marketing Status: Prescription
Patent and Exclusivity Information
40MG
Marketing Status: Prescription
Active Ingredient: METHYLPHENIDATE HYDROCHLORIDE
Proprietary Name: JORNAY PM
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 40MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N209311
Product Number: 002
Approval Date: Aug 8, 2018
Applicant Holder Full Name: IRONSHORE PHARMACEUTICALS AND DEVELOPMENT INC
Marketing Status: Prescription
Patent and Exclusivity Information
JORNAY PM (METHYLPHENIDATE HYDROCHLORIDE)
Proprietary Name: JORNAY PM
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 40MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N209311
Product Number: 002
Approval Date: Aug 8, 2018
Applicant Holder Full Name: IRONSHORE PHARMACEUTICALS AND DEVELOPMENT INC
Marketing Status: Prescription
Patent and Exclusivity Information
60MG
Marketing Status: Prescription
Active Ingredient: METHYLPHENIDATE HYDROCHLORIDE
Proprietary Name: JORNAY PM
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 60MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N209311
Product Number: 003
Approval Date: Aug 8, 2018
Applicant Holder Full Name: IRONSHORE PHARMACEUTICALS AND DEVELOPMENT INC
Marketing Status: Prescription
Patent and Exclusivity Information
JORNAY PM (METHYLPHENIDATE HYDROCHLORIDE)
Proprietary Name: JORNAY PM
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 60MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N209311
Product Number: 003
Approval Date: Aug 8, 2018
Applicant Holder Full Name: IRONSHORE PHARMACEUTICALS AND DEVELOPMENT INC
Marketing Status: Prescription
Patent and Exclusivity Information
80MG
Marketing Status: Prescription
Active Ingredient: METHYLPHENIDATE HYDROCHLORIDE
Proprietary Name: JORNAY PM
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 80MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N209311
Product Number: 004
Approval Date: Aug 8, 2018
Applicant Holder Full Name: IRONSHORE PHARMACEUTICALS AND DEVELOPMENT INC
Marketing Status: Prescription
Patent and Exclusivity Information
JORNAY PM (METHYLPHENIDATE HYDROCHLORIDE)
Proprietary Name: JORNAY PM
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 80MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N209311
Product Number: 004
Approval Date: Aug 8, 2018
Applicant Holder Full Name: IRONSHORE PHARMACEUTICALS AND DEVELOPMENT INC
Marketing Status: Prescription
Patent and Exclusivity Information
100MG
Marketing Status: Prescription
Active Ingredient: METHYLPHENIDATE HYDROCHLORIDE
Proprietary Name: JORNAY PM
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 100MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N209311
Product Number: 005
Approval Date: Aug 8, 2018
Applicant Holder Full Name: IRONSHORE PHARMACEUTICALS AND DEVELOPMENT INC
Marketing Status: Prescription
Patent and Exclusivity Information
Proprietary Name: JORNAY PM
Dosage Form; Route of Administration: CAPSULE, EXTENDED RELEASE; ORAL
Strength: 100MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N209311
Product Number: 005
Approval Date: Aug 8, 2018
Applicant Holder Full Name: IRONSHORE PHARMACEUTICALS AND DEVELOPMENT INC
Marketing Status: Prescription
Patent and Exclusivity Information